Isolated ferric reductase defective polypeptides and uses thereof
US7189891B2 · kind B2 · utility
1Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2003 |
| Grant date | Mar 13, 2007 |
| Priority date | — |
| Expiry date | Jun 22, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A40/146
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Novel molecules of the multi-drug and toxin efflux (MATE) family of molecules, designated herein as mutant ferric reductase defective (FRD3) nucleic acid and protein molecules are disclosed. The FRD3 nucleic acid and protein molecules are useful as modulating agents in regulating metal homeostasis, e.g., iron homeostasis. The invention further describes transgenic plants in which expression of a FRD3 polypeptide of the invention is altered. Compositions containing FRD3 molecules and methods of using such molecules are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.